ATA-200 Gene Therapy Trial in Patients With LGMDR5
ATA-200 Gene Therapy Trial in Patients With LGMDR5
Active, not recruiting · NCT05973630 · Registry updated 2026-01-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ATA-200 Gene Therapy Trial in Patients With LGMDR5 | autosomal recessive limb-girdle muscular dystrophy type 2C | Active, not recruiting | Phase 1 | 2026-01-29 | NCT05973630 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Atamyo Therapeutics | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Child Health Research Institute | Gainsville | United States | 1 |